Hypothesis

Age‑related loss of the calcium‑binding protein calbindin (CB) in efferent vagal motor neurons of the dorsal motor nucleus of the vagus (DMV) and nucleus ambiguus (NA) impairs parasympathetic output to the intestine, leading to reduced gut motility, barrier dysfunction, and secondary microbiome shifts that drive cognitive decline.

Mechanistic Basis

• Aging cholinergic neurons show 50‑100 % higher basal intracellular Ca²⁺ and slowed Ca²⁺ clearance when CB is depleted[3][4].
• Efferent vagal neurons are highly active, glutamatergic/cholinergic, and thus rely on CB to buffer Ca²⁺ during repetitive firing.
• CB loss predicts hyper‑excitable, then fatigued, vagal firing, decreasing acetylcholine release at gut‑targeted synapses.
• Reduced vagal tone diminishes mucosal blood flow, tight‑junction protein expression, and antimicrobial peptide secretion, increasing intestinal permeability.
• Barrier leakage allows microbial metabolites (e.g., 3‑hydroxyoctanoic acid) to reach the portal circulation, activating afferent vagal fibers and inflammatory pathways that impair hippocampal interoceptive signaling[2].
• The resulting microbiome‑derived signals are thus a consequence of primary efferent vagal failure, not the initial cause.

Testable Predictions

1. In aged mice, CB immunoreactivity will be significantly lower in DMV/NA cholinergic neurons compared with young adults.
2. Optogenetic stimulation of DMV vagal motor neurons will rescue gut motility and barrier integrity in aged CB‑knockout mice, normalizing fecal metabolite profiles.
3. Pharmacological enhancement of vagal efferent signaling (e.g., with acetylcholinesterase inhibitors) will attenuate age‑related increases in circulating 3‑hydroxyoctanoic acid and improve memory performance, even when the microbiome is left unchanged.
4. Selective CB overexpression in DMV neurons will extend lifespan and preserve cognitive function in a manner independent of fecal microbiota transplantation from young donors.

Experimental Approach

• Use CB‑floxed mice crossed with ChAT‑Cre to delete CB specifically in cholinergic vagal motor neurons; verify loss via immunostaining[3].
• Measure in vivo vagal efferent activity using extracellular recordings from the cervical vagus during gut distension.
• Assess gut transit (fluorescence bead assay), permeability (FITC‑dextran serum levels), and tight‑junction (occludin, claudin‑1) expression.
• Perform 16S rRNA sequencing and targeted metabolomics for microbial products.
• Cognitive testing: novel object recognition and radial arm maze.
• Lifespan monitoring under ad libitum and caloric restriction conditions.

Potential Confounds and Controls

• Ensure that observed gut changes are not secondary to altered food intake; pair‑fed controls.
• Confirm that CB deletion does not affect afferent vagal sensory neurons (use separate sensory‑neuron Cre line).
• Control for off‑target effects of optogenetic or pharmacological manipulations with appropriate viral vectors and vehicle treatments.

By inverting the prevailing gut→brain causality, this hypothesis positions efferent vagal calcium homeostasis as a upstream regulator of intestinal health and, consequently, brain aging. Demonstrating that restoring vagal efferent function mitigates gut‑derived inflammatory signals would redirect longevity interventions toward bolstering central autonomic output rather than solely remodeling the microbiome.